Stock Analysis on Net

DexCom Inc. (NASDAQ:DXCM)

This company has been moved to the archive! The financial data has not been updated since October 26, 2023.

Analysis of Long-term (Investment) Activity Ratios 

Microsoft Excel

Long-term Activity Ratios (Summary)

DexCom Inc., long-term (investment) activity ratios

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Net fixed asset turnover 2.76 3.05 3.74 4.59 5.63
Net fixed asset turnover (including operating lease, right-of-use asset) 2.56 2.75 3.17 3.76 5.63
Total asset turnover 0.54 0.50 0.45 0.62 0.54
Equity turnover 1.36 1.09 1.05 1.67 1.56

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

Long-term activity ratio Description The company
Net fixed asset turnover An activity ratio calculated as total revenue divided by net fixed assets. DexCom Inc. net fixed asset turnover ratio deteriorated from 2020 to 2021 and from 2021 to 2022.
Net fixed asset turnover (including operating lease, right-of-use asset) An activity ratio calculated as total revenue divided by net fixed assets (including operating lease, right-of-use asset). DexCom Inc. net fixed asset turnover ratio (with operating lease, right-of-use asset) deteriorated from 2020 to 2021 and from 2021 to 2022.
Total asset turnover An activity ratio calculated as total revenue divided by total assets. DexCom Inc. total asset turnover ratio improved from 2020 to 2021 and from 2021 to 2022.
Equity turnover An activity ratio calculated as total revenue divided by shareholders’ equity. DexCom Inc. equity turnover ratio improved from 2020 to 2021 and from 2021 to 2022.

Net Fixed Asset Turnover

DexCom Inc., net fixed asset turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in thousands)
Revenue 2,909,800 2,448,500 1,926,700 1,476,000 1,031,600
Property and equipment, net 1,055,600 801,800 515,300 321,300 183,100
Long-term Activity Ratio
Net fixed asset turnover1 2.76 3.05 3.74 4.59 5.63
Benchmarks
Net Fixed Asset Turnover, Competitors2
Abbott Laboratories 4.76 4.81 3.83 3.97
Cigna Group 47.53 46.73 37.85 34.45
CVS Health Corp. 24.98 22.56 21.25 21.24
Elevance Health Inc. 36.07 34.94 34.69 32.92
Humana Inc. 28.71 26.97 32.05 32.93
Intuitive Surgical Inc. 2.62 3.04 2.76 3.52
Medtronic PLC 5.85 5.77 5.99 6.54
UnitedHealth Group Inc. 31.81 31.81 29.64 27.60
Net Fixed Asset Turnover, Sector
Health Care Equipment & Services 22.49 21.55 20.28 19.95
Net Fixed Asset Turnover, Industry
Health Care 10.62 10.44 9.62 9.73

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Net fixed asset turnover = Revenue ÷ Property and equipment, net
= 2,909,800 ÷ 1,055,600 = 2.76

2 Click competitor name to see calculations.

Long-term activity ratio Description The company
Net fixed asset turnover An activity ratio calculated as total revenue divided by net fixed assets. DexCom Inc. net fixed asset turnover ratio deteriorated from 2020 to 2021 and from 2021 to 2022.

Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset)

DexCom Inc., net fixed asset turnover (including operating lease, right-of-use asset) calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in thousands)
Revenue 2,909,800 2,448,500 1,926,700 1,476,000 1,031,600
 
Property and equipment, net 1,055,600 801,800 515,300 321,300 183,100
Operating lease right-of-use assets 80,000 88,100 93,300 71,500
Property and equipment, net (including operating lease, right-of-use asset) 1,135,600 889,900 608,600 392,800 183,100
Long-term Activity Ratio
Net fixed asset turnover (including operating lease, right-of-use asset)1 2.56 2.75 3.17 3.76 5.63
Benchmarks
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Competitors2
Abbott Laboratories 4.25 4.26 3.42 3.56
Cigna Group 43.23 41.37 33.46 30.72
CVS Health Corp. 10.46 9.09 8.04 7.77
Elevance Health Inc. 31.64 30.12 29.26 27.82
Humana Inc. 24.76 22.09 27.07 27.22
Intuitive Surgical Inc. 2.53 2.93 2.66 3.32
Medtronic PLC 5.06 4.84 5.02 6.54
UnitedHealth Group Inc. 21.54 21.54 19.55 18.97
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Sector
Health Care Equipment & Services 14.87 13.78 12.53 12.33
Net Fixed Asset Turnover (including Operating Lease, Right-of-Use Asset), Industry
Health Care 8.57 8.28 7.55 7.63

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Net fixed asset turnover (including operating lease, right-of-use asset) = Revenue ÷ Property and equipment, net (including operating lease, right-of-use asset)
= 2,909,800 ÷ 1,135,600 = 2.56

2 Click competitor name to see calculations.

Long-term activity ratio Description The company
Net fixed asset turnover (including operating lease, right-of-use asset) An activity ratio calculated as total revenue divided by net fixed assets (including operating lease, right-of-use asset). DexCom Inc. net fixed asset turnover ratio (with operating lease, right-of-use asset) deteriorated from 2020 to 2021 and from 2021 to 2022.

Total Asset Turnover

DexCom Inc., total asset turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in thousands)
Revenue 2,909,800 2,448,500 1,926,700 1,476,000 1,031,600
Total assets 5,391,700 4,863,600 4,290,500 2,395,000 1,916,000
Long-term Activity Ratio
Total asset turnover1 0.54 0.50 0.45 0.62 0.54
Benchmarks
Total Asset Turnover, Competitors2
Abbott Laboratories 0.59 0.57 0.48 0.47
Cigna Group 1.25 1.11 1.02 0.98
CVS Health Corp. 1.41 1.25 1.16 1.15
Elevance Health Inc. 1.51 1.41 1.39 1.33
Humana Inc. 2.15 1.87 2.17 2.21
Intuitive Surgical Inc. 0.48 0.42 0.39 0.46
Medtronic PLC 0.35 0.32 0.32 0.34
UnitedHealth Group Inc. 1.31 1.34 1.30 1.38
Total Asset Turnover, Sector
Health Care Equipment & Services 1.22 1.13 1.08 1.07
Total Asset Turnover, Industry
Health Care 0.81 0.76 0.70 0.71

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Total asset turnover = Revenue ÷ Total assets
= 2,909,800 ÷ 5,391,700 = 0.54

2 Click competitor name to see calculations.

Long-term activity ratio Description The company
Total asset turnover An activity ratio calculated as total revenue divided by total assets. DexCom Inc. total asset turnover ratio improved from 2020 to 2021 and from 2021 to 2022.

Equity Turnover

DexCom Inc., equity turnover calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Selected Financial Data (US$ in thousands)
Revenue 2,909,800 2,448,500 1,926,700 1,476,000 1,031,600
Stockholders’ equity 2,131,800 2,251,500 1,826,500 882,600 663,300
Long-term Activity Ratio
Equity turnover1 1.36 1.09 1.05 1.67 1.56
Benchmarks
Equity Turnover, Competitors2
Abbott Laboratories 1.19 1.20 1.06 1.03
Cigna Group 4.00 3.66 3.16 3.36
CVS Health Corp. 4.53 3.87 3.86 4.00
Elevance Health Inc. 4.29 3.80 3.64 3.25
Humana Inc. 6.04 5.15 5.54 5.35
Intuitive Surgical Inc. 0.56 0.48 0.45 0.54
Medtronic PLC 0.60 0.59 0.57 0.61
UnitedHealth Group Inc. 4.14 3.98 3.90 4.17
Equity Turnover, Sector
Health Care Equipment & Services 3.34 3.03 2.91 2.94
Equity Turnover, Industry
Health Care 2.17 2.10 2.07 2.07

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).

1 2022 Calculation
Equity turnover = Revenue ÷ Stockholders’ equity
= 2,909,800 ÷ 2,131,800 = 1.36

2 Click competitor name to see calculations.

Long-term activity ratio Description The company
Equity turnover An activity ratio calculated as total revenue divided by shareholders’ equity. DexCom Inc. equity turnover ratio improved from 2020 to 2021 and from 2021 to 2022.